Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2018

Jan 26, 2018

33003_dirs_2018-01-25_873ffdd7-4378-4e95-83ea-dbcc9d0e6004.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences, LLC (SLDB)
CIK: 0001707502
Period of Report: 2018-01-25

Reporting Person: JPMORGAN CHASE & CO (10% Owner)
Reporting Person: JPMC Strategic Investments II Corp (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3031601 Indirect

Footnotes

F1: JPMC Strategic Investments II Corporation is the record holder of 3,031,601 shares of Common Stock. JPMC Strategic Investments II Corporation is a wholly-owned subsidiary of JPMorgan Chase & Co., a publicly traded entity listed on the New York Stock Exchange.

F2: Upon the consummation of the initial public offering of Solid Biosciences Inc., the reporting persons will own less than 10% of the outstanding shares of Common Stock of Solid Biosciences.